Oncology
Early Breast Cancer
Conference Reporter® in HR+/HER2- Early Breast Cancer to Cover Key Topics Being Presented at SABCS 2026
Overview
Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in HR+/HER2- Early Breast Cancer presented at the San Antonio Breast Cancer Symposium 2026.
VIEW THE TOPICS:
- Managing Endocrine Therapy–Related Side Effects and Adherence in HR+/HER2- Early-Stage Breast Cancer
- Multigene Assays and the Management of HR+/HER2- Early-Stage Breast Cancer
- Selecting Patients for Adjuvant CDK4/6 Inhibitor Therapy: Moving From Trial Criteria to Real-World Practice
This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the San Antonio Breast Cancer Symposium.
SABCS 2026
December 8 – December 11, 2026
Henry B. Gonzalez Convention Center
San Antonio, TX